Literature DB >> 34040230

Mining for METTL3 inhibitors to suppress cancer.

Jiazhi Li1,2, Richard I Gregory3,4,5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34040230      PMCID： PMC8197751          DOI： 10.1038/s41594-021-00606-5

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN： 1545-9985            Impact factor:   15.369


× No keyword cloud information.
  1 in total

1.  Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.

Authors:  Eliza Yankova; Wesley Blackaby; Mark Albertella; Justyna Rak; Etienne De Braekeleer; Georgia Tsagkogeorga; Ewa S Pilka; Demetrios Aspris; Dan Leggate; Alan G Hendrick; Natalie A Webster; Byron Andrews; Richard Fosbeary; Patrick Guest; Nerea Irigoyen; Maria Eleftheriou; Malgorzata Gozdecka; Joao M L Dias; Andrew J Bannister; Binje Vick; Irmela Jeremias; George S Vassiliou; Oliver Rausch; Konstantinos Tzelepis; Tony Kouzarides
Journal:  Nature       Date:  2021-04-26       Impact factor: 69.504
  1 in total
  5 in total

Review 1.  How RNA modifications regulate the antiviral response.

Authors:  Matthew G Thompson; Matthew T Sacco; Stacy M Horner
Journal:  Immunol Rev       Date:  2021-08-17       Impact factor: 12.988

Review 2.  One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.

Authors:  Xianfeng Ouyang; Yuping Gong
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 3.  The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers.

Authors:  Lin Yao; Chang-Feng Man; Rong He; Lian He; Jia-Bin Huang; Shou-Yan Xiang; Zhe Dai; Xiao-Yan Wang; Yu Fan
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

Review 4.  Emerging role of m6A methylation modification in ovarian cancer.

Authors:  Lin-Lin Chang; Xia-Qing Xu; Xue-Ling Liu; Qian-Qian Guo; Yan-Nan Fan; Bao-Xia He; Wen-Zhou Zhang
Journal:  Cancer Cell Int       Date:  2021-12-11       Impact factor: 5.722

Review 5.  Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy.

Authors:  Weiwei Liu; Chaoqun Liu; Hui Wang; Lijun Xu; Jueyu Zhou; Sihua Li; Yu Cheng; Rui Zhou; Liang Zhao
Journal:  Comput Struct Biotechnol J       Date:  2022-09-15       Impact factor: 6.155
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.